Memorial Sloan Kettering Cancer Center
Jamie E Chaft, MD is an Associate Attending Physician at Mememorial Sloan Kettering Cancer Center where she serves as the Director of Early Stage Lung Cancer Research. She designs and leads clinical trials striving to improve the cure rates in early stage lung cancers. In such a capacity, she serves as Study Chair for the NCTN trial of adjuvant nivolumab within the ALCHEMIST program and co-lead of the LCRF LEADER study bringing personalized neoadjuvant therapies to patients with resectable lung cancer. Dr. Chaft's career is committeed to moving drugs shown to have promise in more advanced lung cancers into the early stage setting.
Session 13: Debate: How to Handle PD-L1 >50% - IO Only
Friday, September 22, 2023
1:42 PM – 1:49 PM ET
Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
Friday, September 22, 2023
1:49 PM – 1:56 PM ET
Friday, September 22, 2023
2:03 PM – 2:20 PM ET
Session 13: Debate: How to Handle PD-L1 >50% - IO Only
Thursday, November 30, 2023
1:37 PM – 1:44 PM ET
Session 13: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
Thursday, November 30, 2023
1:44 PM – 1:51 PM ET
Thursday, November 30, 2023
2:00 PM – 2:15 PM ET